– GEN’s Editor-in-Chief John Sterling interviews Michael Cascio, Ph.D., Assistant Professor, Department of Molecular Genetics and Biochemistry, University of Pittsburgh

PodcastsResourcesAnatomyCellular, Molecular and Developmental BiologyCentral nervous systemDrug development (Research and development)DrugsEarly-stage clinical drug developmentIon channelsMedicine, Diagnosis, and TherapeuticsMembraneMembrane biologyNervous systemNovel targets identificationPharmacologyResearch and development
Previous articledeCODE Discovers Variants that Increase the Risk of Atrial Fibrillation
Next articlePanagene Secures License to Commercialize PNA Monomers
Also of Interest
Gene Network Interactions Shed Insight into Breast Cancer Onset and Development
Bruker to Acquire NanoString with $392.6M Winning Bid
New Insights Could Boost Immunotherapy for Rare Eye Cancer
Skin in the Game: Oruka Takes on Blockbuster Drugs for Psoriasis, Dermatological Disorders
StockWatch: Regeneron Shares Dip as DOJ Alleges Fraudulent Price Reporting
Vertex to Acquire Alpine Immune Sciences for $4.9B, Broadening Kidney Drug Pipeline
Related Media
What’s in Store for 2024? Three CEOs Look Ahead and Look Back on “Close to the Edge”
Excitement in Oakland: A Report from SynBioBeta
BIO CEO Rachel King Outlines Industry's Challenges on "Close to the Edge"
Carl Icahn States His Case for Change at Illumina on "Close to the Edge"
Celebrating DNA: Matthew Cobb's Reflections on the Double Helix
Emerging Markets Collaborate to Succeed in Post-Pandemic World